A 55-year-old man without cardiovascular disease, diabetes or chronic kidney disease has an LDL-C of 4.2 mmol/L and total cholesterol/HDL ratio of 6.2. His 10-year Framingham risk is calculated at 18%. According to Canadian dyslipidaemia guidance, which management is most appropriate?